Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease
about
Role of vitamin D in diabetes mellitus and chronic kidney diseaseVascular calcification, bone and mineral metabolism after kidney transplantationKlotho, stem cells, and agingFibroblast growth factor 23Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathwayFGF-23, Klotho and Vitamin D Levels in SclerodermaFibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.The effect of renin angiotensin system genetic variants in acute pancreatitis.A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart diseaseInteractions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 diabetes.Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional studyActive vitamin D treatment for reduction of residual proteinuria: a systematic review.Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patientsRenal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitorFibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trialVitamin D receptor, an important transcription factor associated with aldosterone-producing adenoma.Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease.Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis.Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score AnalysisPlasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.The emerging role of Klotho in clinical nephrology.Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.FGF23 production by osteocytes.Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional linksVitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy.Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial InfaPoststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention.Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantationEffect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.FGF-23 is associated with increased disease severity and early mortality in cardiogenic shockMultiple faces of fibroblast growth factor-23Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.
P2860
Q26765231-F835B51C-2076-4878-BDED-D271680D54A8Q26771400-2BC6615B-3656-4515-A920-04A98359E193Q26783185-4E18EE12-A397-42BE-B483-B51F3CC0FA25Q26829294-65C76430-117E-4009-8932-3255628D9DD8Q27026805-1B59FAB9-0BE2-4B2E-AE15-DD47FB62FC3EQ33711101-F66C8890-D2A3-42F4-A847-B8DB34C5E2FEQ34244300-650B8C41-3630-4D3C-8F13-013CF467D963Q34353579-5BDB68B0-594E-40B5-B2C8-533FF761407EQ34412241-23048A35-2191-4C30-B3E1-4AE881F83899Q34421217-35DD135A-F0F6-4D20-ABD4-A30D2728CAFFQ34506761-C1DDAA71-7823-4162-9244-67E6D89203FFQ34588377-03384455-0DFF-48DD-A946-41AB17166523Q34912750-49E36C1E-852B-4A3D-B5C9-36DA575DC89EQ34941418-C1EA03C8-B0E6-460A-A35A-D0980646D0C1Q34962806-1E7DDD7A-9C3C-403E-9E57-BFA24A608C41Q35008805-7CFAD470-6995-4700-9415-E98C921D8CA9Q35077564-3C900A23-E9FC-4A05-BAB8-AE6D560F2EA5Q35153209-DDA43D89-9ED2-4964-9AE6-91AC8F91EE4EQ35232118-EEC3E709-A07B-4D34-8245-80EC96261E39Q35997370-1066F3AB-7C80-4579-A88F-4B05C663639CQ36001789-28C99420-68E8-450E-A39E-270FB9F1524BQ36015686-3B0FF93A-BB1D-455B-A068-330217AD0CB5Q36074718-054635EA-69E8-41C7-AC89-C90BC4D59345Q36098355-09423E4F-DCC5-470F-A441-7F3DF39AF6C2Q36349451-3C894BA7-5639-40AB-9B15-FDCEC285296DQ36580372-1528923A-F0C5-4BE1-9EC9-DDE3755C70C5Q36639867-D3783719-2E5F-4F8D-B700-1433ABA689B1Q36648170-035E4274-45DD-4D53-A510-1D7F1E77F2A9Q36801566-A009C011-E80A-4764-BA3E-72B7F27FC602Q37152752-84871D97-B14D-439A-BA92-F554F048F761Q37162723-A3828D95-C2B8-4E89-AB05-A580486A3C30Q37177523-A2EC411E-3972-4917-A4EF-3AFE65AD7EF7Q37239835-BF6372BD-FF1A-49E7-B694-28CB52517DA7Q37280819-B21CE6FB-073B-4544-86AD-84B0EC1871B2Q37280832-19FF442B-9466-4FDE-9917-098E81E8868CQ37291894-996358B0-C7E3-4470-BC79-5CBD8188C8C7Q37312020-C802EF72-9F2F-4A95-AFF3-68C5DD2FA2CDQ37342971-1A6FDAB8-5200-4A3E-B43C-E65E4563A86FQ37432867-46361FD1-BC4D-4C6D-899C-6FD4FD90E027Q37690771-5EB87F56-2615-4618-90C4-59409082EDDE
P2860
Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cross talk between the renin-a ...... otho in chronic kidney disease
@ast
Cross talk between the renin-a ...... otho in chronic kidney disease
@en
type
label
Cross talk between the renin-a ...... otho in chronic kidney disease
@ast
Cross talk between the renin-a ...... otho in chronic kidney disease
@en
prefLabel
Cross talk between the renin-a ...... otho in chronic kidney disease
@ast
Cross talk between the renin-a ...... otho in chronic kidney disease
@en
P2093
P2860
P356
P1476
Cross talk between the renin-a ...... otho in chronic kidney disease
@en
P2093
Gerjan Navis
Marc G Vervloet
Martin H de Borst
Piet M ter Wee
P2860
P304
P356
10.1681/ASN.2010121251
P577
2011-08-18T00:00:00Z